Source: Eur Respir J 2011; 38: 1145-1150
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Sahoo D.H., Bandyopadhyay D., Xu M., Pearson K., Parambil J.G., Lazar C.A., Chapman J.T., Culver D.A.. Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis. Eur Respir J 2011; 38: 1145-1150

Member's Comments

No comment yet.

Related content which might interest you: Infliximab: An effective rescue therapy in refractory extra-pulmonary sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial Source: Eur Respir J 2008; 31: 1189-1196 Year: 2008 The course of COVID-19 in pulmonary sarcoidosis patients, receiving methotrexate Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis Year: 2021 Azathioprine and low-dose prednisone in chronic pulmonary sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 268s Year: 2005 Methotrexate in the treatment of the chronic form of pulmonary and extra - pulmonary sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 712s Year: 2004 Sulphasalazine and lung toxicity Source: Eur Respir J 2002; 19: 756-764 Year: 2002 Pentoxifylline in treatment of pulmonary sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 433s Year: 2002 Safety of corticosteroid therapy in patients with pulmonary sarcoidosis Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017 Sarcoidosis Source: Respipedia Article Year: 2017 Severe lung involvement in systemic scleromyxoedema: a highly unusual finding Source: Eur Respir J 2002; 19: 976-979 Year: 2002 The efficacy of treatment with surfactant-BL (S-BL) in patients with destructive pulmonary tuberculosis Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis Year: 2007 Response of pulmonary tuberculomas to anti-tuberculous treatment Source: Eur Respir J 2004; 23: 452-455 Year: 2004 Standard therapy for sarcoidosis Source: Annual Congress 2005 - Biological agents in the therapy of sarcoidosis Year: 2005 Comparison of prednisolone and budesonide in the treatment of pulmonary sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 80s Year: 2005 Methotrexate as a single agent for the treatment of patients with progressive pulmonary sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia Source: Eur Respir J 2005; 25: 528-533 Year: 2005 Does concomitant extrapulmonary involvement changes characteristic features of pulmonary sarcoidosis? Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide Source: Eur Respir J 2002; 20: 127-133 Year: 2002 Granulomatous angiitis leading to a pulmonary veno-occlusive disease-like picture Source: Eur Respir J 2009; 33: 666-669 Year: 2009 Sarcoidosis, a systemic disease Source: Annual Congress 2005 - Sarcoidosis: update on extrathoracic organ problems Year: 2005